The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.00
Bid: 135.80
Ask: 136.20
Change: -0.10 (-0.07%)
Spread: 0.40 (0.295%)
Open: 137.40
High: 137.60
Low: 134.30
Prev. Close: 136.10
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of shares and total voting rights

2 Nov 2023 08:00

RNS Number : 1147S
Aston Martin Lagonda Glob.Hldgs PLC
02 November 2023

2 November 2023

Aston Martin Lagonda Global Holdings plc

("Aston Martin" or the "Company")

Progress to completion of Lucid Transaction and Admission of Consideration SharesTotal Voting Rights

Further to its announcement on 19 September 2023 confirming the receipt of shareholder approvals in connection with the strategic supply arrangement with Lucid Group, Inc. ("Lucid") (the "Transaction"), Aston Martin is today pleased to announce that clearance from all applicable regulatory and antitrust authorities has been obtained and the Transaction can proceed to completion.

Accordingly, the Company announces that, subject and pursuant to the previously disclosed terms of the Transaction:

· 28,352,273 new ordinary shares of £0.10 each in its share capital (the "Consideration Shares") will be allotted and issued to Lucid's subsidiary, Atieva, Inc.

· Integration and supply agreements between Aston Martin and Lucid governing Aston Martin's access to certain of Lucid's industry-leading technologies, including electric powertrains and battery systems, will become effective from Admission of the Consideration Shares

Applications have been made to the Financial Conduct Authority (the "FCA") and the London Stock Exchange plc (the "LSE") respectively for the admission of the Consideration Shares to listing on the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE (together, "Admission"). It is expected that Admission will become effective at 8.00 a.m. on 6 November 2023.

In accordance with the FCA's Disclosure Guidance and Transparency Rules, the Company also notifies that, following Admission becoming effective, the total issued share capital of the Company will be 823,663,785 ordinary shares of £0.10 each with one voting right per share. There are no ordinary shares held in treasury.

Therefore, following Admission becoming effective, the total number of voting rights in the Company will be 823,663,785 and this figure should be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Enquiries

Investors and Analysts

Robert Berg Director of Investor Relations +44 (0) 7833 080458

robert.berg@astonmartin.com

Ella South Investor Relations Analyst +44 (0) 7776 545420

ella.south@astonmartin.com

Media

Kevin Watters Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Paul Garbett Head of Corporate & Brand Communications +44 (0)7501 380799

paul.garbett@astonmartin.com

Teneo

Harry Cameron +44 (0)20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSFFFIILALLIIV
Date   Source Headline
20th Apr 20209:18 amRNSAnnouncement re: Rights Issue
20th Apr 20207:05 amRNSStatement from Executive Chairman, Lawrence Stroll
20th Apr 20207:00 amRNSAnnouncement re: Rights Issue
17th Apr 20202:25 pmRNSHolding(s) in Company
17th Apr 20202:17 pmRNSHolding(s) in Company
17th Apr 20202:14 pmRNSHolding(s) in Company
17th Apr 20202:12 pmRNSHolding(s) in Company
8th Apr 20204:36 pmRNSPrice Monitoring Extension
8th Apr 202010:00 amRNSHolding(s) in Company
8th Apr 20209:00 amRNSAston Martin announces Interim CFO appointment
3rd Apr 20208:15 amRNSSuccessful private placement of nil paid rights
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:45 pmRNSHolding(s) in Company
1st Apr 20203:10 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSAdditional Listing
31st Mar 20207:00 amRNSAdditional Listing
30th Mar 20205:21 pmRNSAnnouncement re: Rights Issue
30th Mar 20205:19 pmRNSResult of Meeting
24th Mar 20201:05 pmRNSUpdate on operations and the impact of COVID-19
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
17th Mar 20202:40 pmRNSAnnual Financial Report
13th Mar 20204:36 pmRNSAnnouncement re: Rights Issue
12th Mar 20204:45 pmRNSSecond Price Monitoring Extn
12th Mar 20204:40 pmRNSPrice Monitoring Extension
28th Feb 202010:00 amRNSTotal Voting Rights
27th Feb 20202:31 pmRNSPublication of a Prospectus
27th Feb 20207:00 amRNSAnnouncement re: Rights Issue
27th Feb 20207:00 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 202011:49 amRNSHolding(s) in Company
21st Feb 202011:31 amRNSHolding(s) in Company
17th Feb 202011:28 amRNSHolding(s) in Company
17th Feb 202011:26 amRNSHolding(s) in Company
17th Feb 202011:22 amRNSHolding(s) in Company
17th Feb 202011:18 amRNSHolding(s) in Company
14th Feb 20203:26 pmRNSDirector/PDMR Shareholding
11th Feb 20203:12 pmRNSDirector/PDMR Shareholding
11th Feb 20203:11 pmRNSHolding(s) in Company
11th Feb 20203:09 pmRNSHolding(s) in Company
11th Feb 20203:05 pmRNSHolding(s) in Company
10th Feb 20204:07 pmRNSPassing Away of Non-Executive Director
31st Jan 20207:00 amRNSIssue of Equity
30th Jan 202010:52 amRNSTotal Voting Rights
7th Jan 20206:01 pmRNSTrading Statement - Clarification
7th Jan 20207:00 amRNSTrading Statement
30th Dec 201910:00 amRNSTotal Voting Rights
16th Dec 201911:10 amRNSHolding(s) in Company
13th Dec 20195:05 pmRNSStatement re Press Comment
11th Dec 20194:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.